Is there a role for immunocontraception?

E. A. McLaughlin, R. J. Aitken

Research output: Contribution to journalReview article

27 Citations (Scopus)

Abstract

The world's population is continuing to grow at an alarming rate and yet no novel methods of contraception have been introduced since 1960s. The paucity of our current contraceptive armoury is indicated by the 46 million abortions that are performed each year, largely in developing countries where population growth is greatest. Thus, whatever new forms of fertility control we develop for the next millennium, the particular needs of developing countries should be borne in mind. Contraceptive vaccines have the potential to provide safe, effective, prolonged, reversible protection against pregnancy in a form that can be easily administered in the Third World. In this review we consider the contraceptive targets that might be pursued, how vaccines might be engineered and the problems generated by inter-individual variations in antibody titre. We conclude that the specifications for a safe, effective, reversible vaccine are more likely to be met in animals than man.

Original languageEnglish
Pages (from-to)78-88
Number of pages11
JournalMolecular and Cellular Endocrinology
Volume335
Issue number1
DOIs
Publication statusPublished - 15 Mar 2011
Externally publishedYes

Fingerprint

Immunologic Contraception
Contraceptive Agents
Contraception
Developing countries
Developing Countries
Contraceptive Vaccines
Vaccines
Population Growth
Animals
Specifications
Pregnancy
Antibodies
Population

Cite this

@article{7cb77f9c1cb747198e770ad085283347,
title = "Is there a role for immunocontraception?",
abstract = "The world's population is continuing to grow at an alarming rate and yet no novel methods of contraception have been introduced since 1960s. The paucity of our current contraceptive armoury is indicated by the 46 million abortions that are performed each year, largely in developing countries where population growth is greatest. Thus, whatever new forms of fertility control we develop for the next millennium, the particular needs of developing countries should be borne in mind. Contraceptive vaccines have the potential to provide safe, effective, prolonged, reversible protection against pregnancy in a form that can be easily administered in the Third World. In this review we consider the contraceptive targets that might be pursued, how vaccines might be engineered and the problems generated by inter-individual variations in antibody titre. We conclude that the specifications for a safe, effective, reversible vaccine are more likely to be met in animals than man.",
keywords = "Adjuvant, Contraception, Mucosal immunity, Systemic immunity, Target antigens, Vaccine",
author = "McLaughlin, {E. A.} and Aitken, {R. J.}",
year = "2011",
month = "3",
day = "15",
doi = "10.1016/j.mce.2010.04.004",
language = "English",
volume = "335",
pages = "78--88",
journal = "Molecular and Cellular Endocrinology",
issn = "0303-7207",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

Is there a role for immunocontraception? / McLaughlin, E. A.; Aitken, R. J.

In: Molecular and Cellular Endocrinology, Vol. 335, No. 1, 15.03.2011, p. 78-88.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Is there a role for immunocontraception?

AU - McLaughlin, E. A.

AU - Aitken, R. J.

PY - 2011/3/15

Y1 - 2011/3/15

N2 - The world's population is continuing to grow at an alarming rate and yet no novel methods of contraception have been introduced since 1960s. The paucity of our current contraceptive armoury is indicated by the 46 million abortions that are performed each year, largely in developing countries where population growth is greatest. Thus, whatever new forms of fertility control we develop for the next millennium, the particular needs of developing countries should be borne in mind. Contraceptive vaccines have the potential to provide safe, effective, prolonged, reversible protection against pregnancy in a form that can be easily administered in the Third World. In this review we consider the contraceptive targets that might be pursued, how vaccines might be engineered and the problems generated by inter-individual variations in antibody titre. We conclude that the specifications for a safe, effective, reversible vaccine are more likely to be met in animals than man.

AB - The world's population is continuing to grow at an alarming rate and yet no novel methods of contraception have been introduced since 1960s. The paucity of our current contraceptive armoury is indicated by the 46 million abortions that are performed each year, largely in developing countries where population growth is greatest. Thus, whatever new forms of fertility control we develop for the next millennium, the particular needs of developing countries should be borne in mind. Contraceptive vaccines have the potential to provide safe, effective, prolonged, reversible protection against pregnancy in a form that can be easily administered in the Third World. In this review we consider the contraceptive targets that might be pursued, how vaccines might be engineered and the problems generated by inter-individual variations in antibody titre. We conclude that the specifications for a safe, effective, reversible vaccine are more likely to be met in animals than man.

KW - Adjuvant

KW - Contraception

KW - Mucosal immunity

KW - Systemic immunity

KW - Target antigens

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=79951578499&partnerID=8YFLogxK

U2 - 10.1016/j.mce.2010.04.004

DO - 10.1016/j.mce.2010.04.004

M3 - Review article

VL - 335

SP - 78

EP - 88

JO - Molecular and Cellular Endocrinology

JF - Molecular and Cellular Endocrinology

SN - 0303-7207

IS - 1

ER -